Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | -1.32% | -2.30% | -7.45% |
May. 14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
May. 14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.07M | Sales 2025 * | 54.11M | Capitalization | 212M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -22M | EV / Sales 2024 * | 102 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.92 x |
P/E ratio 2024 * |
-3.47
x | P/E ratio 2025 * |
-10.6
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.13% |
Latest transcript on Ovid Therapeutics Inc.
1 day | -1.32% | ||
1 week | -2.30% | ||
Current month | -2.61% | ||
1 month | -2.61% | ||
3 months | -10.78% | ||
6 months | -6.88% | ||
Current year | -7.45% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.46% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 2.99 | -0.99% | 119,856 |
24-06-03 | 3.02 | -1.31% | 136,141 |
24-05-31 | 3.06 | 0.00% | 78,572 |
24-05-30 | 3.06 | +2.00% | 165,122 |
24-05-29 | 3 | -1.64% | 120,082 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.45% | 212M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+1.69% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- OVID Stock